About the Centers of Excellence
The Louisiana State University Health Sciences Center New Orleans Centers of Excellence were established by the Louisiana State University Board of Regents. The Centers of Excellence consist of the following ten centers:
Alcohol and Drug Abuse Center
This Center enhances the research capabilities of scientists, stimulates collaborative research efforts and strengthens educational activities in the biomedical aspects of alcohol and substance abuse throughout the Health Sciences Center.
The goal of the Cardiovascular Center is to improve the understanding and management of cardiovascular diseases by developing a multidisciplinary approach that integrates close, collaborative efforts among programs in basic and clinical research, clinical management, prevention, and epidemiologic and genetic studies.
Center for Molecular and Human Genetics
Augment the contribution of genetics to clinical medicine and biotechnology, clinical genetic services, training and education in genetics augment the contribution of genetics to clinical medicine and biotechnology, and more.
The Epilepsy Center is dedicated to pediatric and adult education, advanced medical care, and to developing treatments that will eventually cure epilepsy and seizures for the nearly 4% of the population affected by seizures or epilepsy. The Center provides state of the art epilepsy research in pharmacology, neuroelectrophysiology, neuroimaging, neurosurgery, biomedical engineering and public health. The Center also supports the oldest continuously operating quarternary epilepsy program in Louisiana and the central Gulf south (est.1990) providing epilepsy monitoring, advanced medications, vagus nerve stimulator implantation, epilepsy surgery and gamma knife surgery. In Louisiana, all citizens that continue to have seizures despite routine medications should be referred to the Center's clinical epilepsy team for further evaluation.
The Eye Center faculty is known for pioneering work in laser vision correction, cataract and other refractive surgeries, viral and bacterial eye disease, corneal transplantation and cornea preservation, confocal microscopy, glaucoma, wound healing, drug delivery, contact lenses, diabetic eye disease, macular degeneration, retinitis pigmentosa and other retinal diseases and degeneration.
Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center
A center dedicated to patient education, advanced patient care, and to finding the answers that will eventually cure asthma.
Gene Therapy Program
The Gene Therapy Program is focused on the development of novel treatments for human disease, including cancer, infectious diseases such as HIV/AIDS and TB, cystic fibrosis, and neurodegenerative disorders. The major research strategy of the Program is gene delivery for disease therapy or prevention, either through the replacement of “missing” genes, or via modulation of immune function through delivery of vaccine antigens or immune response modifiers. The Program is an integral component of the Louisiana Gene Therapy Research Consortium and interacts extensively with partner Programs at LSU-Shreveport and Tulane.
The mission of the Center is to contribute to the creation of an environment of high standards, where investigations on the nervous system and the diseases that affect it are conducted. To this end, the identification and recruitment of outstanding faculty to build a critical mass of expertise is already a tangible asset.
Research Institute for Children
The Research Institute for Children (RIC) established in 1998 is a joint collaboration among Children’s Hospital, LSU Health Sciences Center (New Orleans) and the University of New Orleans. The RIC is housed in the Research and Education Building on the Children’s Hospital campus and is supported by Children’s Hospital. The overall objective of the RIC is to promote and conduct medical and basic science research in the diagnosis, treatment, and prevention of pediatric illnesses, particularly infectious diseases, and diabetes. A secondary objective is to provide research training for academic scientists, both basic and translational. To accomplish this, a strong core of basic scientists interacts with clinical faculty from LSUHSC and Children’s Hospital. Trainees include undergraduate and graduate students, and both clinical and basic postdoctoral fellows. The individuals trained within these basic science laboratories will become the translational and clinical researchers who fulfill the ultimate mission of the RIC.
Stanley S. Scott Cancer Center
The mission of the Stanley S. Scott Cancer Center is to decrease cancer incidence and mortality in the State of Louisiana. Particular emphasis at the Cancer Center is placed on those citizens with the greatest need.
The Louisiana Vaccine Center (2009)
The Louisiana Vaccine Center focuses interdisciplinary strengths in the basic and translational science of microbial pathogenesis, immunity and vaccine research to foster development of novel vaccines and therapies against infectious disease. The Center encompasses LSUHSC-New Orleans, Tulane HSC, and Xavier University of Louisiana, and is directed towards building a tower of strength, with education, research and development infrastructure to support growth and the commercialization of new discoveries. The Center has developed and consolidated excellent facilities and support services designed to aid the flow of vaccine-related research from discovery through pre-clinical testing and analysis. Center-driven education programs in infectious disease and vaccines span training opportunities for high school students, undergraduates and graduate fellows, and include entrepreneurial fellowships developed in partnership with the New Orleans BioInnovation Center. The Center thus fosters education in infectious disease and vaccines, promotes research collaborations between partner institutions, strengthens our capacity to compete for large-scale research and development grants and contracts, provides a focus for recruitment and retention of established researchers and junior scientists, and facilitates research commercialization and new local biotechnology ventures.